The impact of CYP2C19 genotype on cardiovascular events and platelet reactivity in patients with coronary artery disease receiving clopidogrel. (Q46219234)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | The impact of CYP2C19 genotype on cardiovascular events and platelet reactivity in patients with coronary artery disease receiving clopidogrel. |
scientific article |
Statements
The impact of CYP2C19 genotype on cardiovascular events and platelet reactivity in patients with coronary artery disease receiving clopidogrel (English)
Christodoulos Stefanadis
Dimitris Tousoulis
Athanasios G Papavassiliou
Stamatios Kioufis
Marina Zaromitidou
Konstantinos Maniatis
10 February 2013